News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
538,723 Results
Type
Article (14622)
Company Profile (170)
Press Release (523930)
Multimedia
Podcasts (35)
Webinars (10)
Section
Business (181808)
Career Advice (377)
Deals (27962)
Drug Delivery (23)
Drug Development (62334)
Employer Resources (22)
FDA (11271)
Job Trends (9943)
News (263726)
Policy (20154)
Tag
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (4)
2027 Biotech Bay Standard (7)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (3)
2027 Genetown Standard (3)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (3)
Academia (761)
Accelerated approval (42)
ADA (21)
Adcomms (17)
Allergies (101)
Alliances (37822)
ALS (131)
Alzheimer's disease (1062)
Antibody-drug conjugate (ADC) (536)
Approvals (11970)
Artificial intelligence (507)
ASCO (337)
Autoimmune disease (279)
Automation (33)
Bankruptcy (282)
Belgium (1)
Best Places to Work (8104)
BIO (54)
Biologics (10)
BIOSECURE Act (2)
Biosimilars (179)
BioSpace Insights (40)
Biotechnology (114)
Bispecific (1)
Bladder cancer (204)
Brain cancer (71)
Breast cancer (787)
Cancer (6142)
Cardiovascular disease (257)
Career advice (315)
Career pathing (8)
CAR-T (275)
CDC (6)
CDMO (60)
Celiac Disease (1)
Cell therapy (691)
Cervical cancer (49)
Clinical research (56580)
Collaboration (1768)
Commercialization (5)
Company closure (2)
Compensation (1574)
Complete response letters (52)
COVID-19 (961)
CRISPR (77)
C-suite (1037)
Cystic fibrosis (89)
Data (7205)
Decentralized trials (1)
Denatured (9)
Depression (112)
Dermatology (76)
Diabetes (372)
Diagnostics (4958)
Digital health (42)
Diversity (3)
Diversity, equity & inclusion (8)
Drug discovery (252)
Drug pricing (32)
Drug shortages (3)
Duchenne muscular dystrophy (198)
Earnings (77241)
Editorial (21)
Employer branding (3)
Employer resources (24)
Events (97211)
Executive appointments (887)
FDA (14526)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (18)
Frontotemporal dementia (24)
Funding (1207)
Gene editing (152)
Generative AI (36)
Gene therapy (404)
GLP-1 (398)
Government (1313)
Grass and pollen (2)
Guidances (317)
Healthcare (11254)
Hematology (148)
HIV (64)
Huntington's disease (24)
IgA nephropathy (78)
Immunology and inflammation (163)
Immuno-oncology (133)
Indications (206)
Infectious disease (1181)
Inflammatory bowel disease (151)
Inflation Reduction Act (6)
Influenza (89)
Intellectual property (283)
Interviews (53)
IPO (13337)
IRA (10)
Job creations (2236)
Job search strategy (290)
JPM (27)
Kidney cancer (27)
Labor market (12)
Layoffs (188)
Leadership (9)
Legal (5396)
Licensing (24)
Liver cancer (81)
Longevity (22)
Lung cancer (900)
Lymphoma (409)
Machine learning (44)
Management (5)
Manufacturing (697)
Marketing (9)
MASH (129)
Medical affairs (2)
Medical device (9035)
Medtech (9201)
Mergers & acquisitions (15780)
Metabolic disorders (821)
mRNA (145)
Multiple sclerosis (123)
NASH (5)
Neurodegenerative disease (256)
Neuropsychiatric disorders (50)
Neuroscience (2058)
NextGen: Class of 2026 (3692)
Non-profit (1286)
Now hiring (28)
Obesity (291)
Opinion (60)
Ovarian cancer (238)
Pain (188)
Pancreatic cancer (356)
Parkinson's disease (221)
Partnered (12)
Patents (565)
Patient recruitment (661)
Patient selection (2)
Peanut (32)
People (46139)
Peptides (3)
Pharmaceutical (38)
Pharmacy benefit managers (10)
Phase 1 (18530)
Phase 2 (24880)
Phase 3 (17689)
Pipeline (9095)
Policy (68)
Postmarket research (1803)
Preclinical (7558)
Press Release (35)
Prostate cancer (316)
Psychedelics (11)
Radiopharmaceuticals (334)
Rare diseases (714)
Real estate (3467)
Recruiting (11)
Regenerative medicine (2)
Regulatory (17484)
Reports (27)
Research institute (1166)
Resumes & cover letters (52)
Rett syndrome (42)
RNA editing (7)
RSV (56)
Schizophrenia (118)
Series A (219)
Series B (146)
Service/supplier (6)
Sickle cell disease (86)
Special edition (5)
Spinal muscular atrophy (94)
Sponsored (12)
Startups (2485)
State (1)
Stomach cancer (14)
Supply chain (60)
Tariffs (8)
The Weekly (25)
Vaccines (455)
Venture capital (59)
Weight loss (107)
Women's health (95)
Date
Last 7 days (355)
Last 30 days (1608)
Last 365 days (22651)
2026 (16224)
2025 (22671)
2024 (26538)
2023 (30396)
2022 (39037)
2021 (41595)
2020 (37494)
2019 (27338)
2018 (20466)
2017 (22019)
2016 (20871)
2015 (26900)
2014 (23409)
2013 (19471)
2012 (21443)
2011 (21706)
2010 (21323)
Location
Africa (294)
Alabama (93)
Alaska (3)
Arizona (320)
Arkansas (13)
Asia (24754)
Australia (3284)
California (13220)
Canada (3539)
China (1125)
Colorado (524)
Connecticut (462)
Delaware (418)
Europe (40567)
Florida (1974)
Georgia (402)
Hawaii (3)
Idaho (49)
Illinois (929)
India (75)
Indiana (423)
Iowa (18)
Japan (523)
Kansas (113)
Kentucky (41)
Louisiana (29)
Maine (26)
Maryland (1395)
Massachusetts (9257)
Michigan (323)
Minnesota (626)
Mississippi (4)
Missouri (91)
Montana (24)
Nebraska (11)
Nevada (126)
New Hampshire (65)
New Jersey (3041)
New Mexico (16)
New York (3161)
North Carolina (1441)
North Dakota (4)
Northern California (6689)
Ohio (315)
Oklahoma (14)
Oregon (21)
Pennsylvania (2563)
Puerto Rico (26)
Rhode Island (32)
South America (474)
South Carolina (80)
South Dakota (1)
Southern California (5448)
Tennessee (158)
Texas (2184)
United States (44207)
Utah (386)
Vermont (1)
Virginia (186)
Washington D.C. (46)
Washington State (1010)
West Virginia (1)
Wisconsin (106)
Wyoming (1)
538,723 Results for "ilex oncology inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Job Trends
Do you need oncology experience to land an oncology job?
Business stage is just one factor in whether biopharmas want job candidates to have oncology experience for oncology roles. Two recruiters explain when oncology expertise matters most, the mistakes job seekers make and how to make a good impression.
July 29, 2026
·
5 min read
·
Angela Gabriel
Press Releases
Neovia Oncology Files New Patent Following Discovery of Dual Topoisomerase I/II Catalytic Inhibition
Independent studies establish a differentiated mechanism for clinical-stage NEV-801 and reveal broader potential for Neovia’s proprietary oncology and ADC payload portfolio.
September 4, 2026
·
1 min read
Press Releases
Citius Oncology, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
August 16, 2026
·
14 min read
Press Releases
Solstice Oncology Launches with $225 Million Series A Financing to Advance Porustobart, a Neoadjuvant Immuno-Oncology Therapy
September 9, 2026
·
6 min read
Press Releases
Champions Oncology Reports Revenue of $15.2 Million
September 10, 2026
·
12 min read
Press Releases
Johnson & Johnson Completes Acquisition of Firefly Bio, Inc. to Advance Next-Generation Oncology Innovation
July 29, 2026
·
6 min read
Opinion
CAR T for autoimmune disease benefits from oncology’s lessons—and will deliver its own
Thanks in part to the revolution cell therapy brought to treating blood cancers, the modality is now showing promise in some autoimmune applications. This expansion is poised to yield even wider benefits.
August 28, 2026
·
6 min read
·
Deborah Phippard
Press Releases
Harbour BioMed Partner, Solstice Oncology, announces $225 Million Series A Financing to Advance Porustobart, a Neoadjuvant Immuno-Oncology Therapy
September 9, 2026
·
5 min read
Press Releases
Cardiff Oncology to Participate in September 2026 Conferences
September 2, 2026
·
1 min read
Press Releases
Lupin Spins Out Two Oncology Programs to Kaveri Therapeutics to Advance its Oncology Strategy
July 21, 2026
·
3 min read
1 of 53,873
Next
